Pradaxa Lawsuit News and Information
The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: Users of Pradaxa who suffered severe internal bleeding, hemorrhages or other problems may be eligible to pursue a Pradaxa lawsuit. Lawyers are reviewing potential claims for individuals throughout […]
All Articles Tagged With: "Pradaxa"
An analysis of FDA adverse event reports showing Eliquis to be the safest of the new blood thinners has come under fire from other manufacturers of competing drugs.
The makers of Pradaxa failed to show the FDA an analysis indicating an increasing rate of fatal bleeding events, court documents suggest.
A Canadian research institute is embroiled in Pradaxa litigation and faces questions about the integrity of its clinical trial data.
A Kentucky woman has filed a lawsuit claiming that side effects of Xarelto caused her to suffer internal bleeding, raising similar allegations to those raised in Pradaxa lawsuits.
The FDA has rejected expanded use for the blood thinner Xarelto for a third time.
Boehringer Ingelheim now faces more than 2,000 Pradaxa lawsuits by plaintiffs who claim the drug causes dangerous bleeding events.
New documents suggest that the makers of Pradaxa hid data showing that users may need regular testing and potentially altered the conclusions of a scientific research paper.
An appeals court upheld some sanctions against the makers of Pradaxa and overturned others, which were meant to punish the company for acting in bad faith during litigation.
Judge Herndon has identified the first four Pradaxa lawsuits that will go to trial in the federal MDL, with trial dates set to begin between August 2014 and February 2015.
An FDA advisory panel recommends that the agency reject calls to expand the use of Xarelto.
Contact a LawyerSubmit information about your potential case to be reviewed by an attorney.